Detalhe da pesquisa
1.
A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours.
BMC Cancer
; 20(1): 1118, 2020 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203399